Personal information

No personal information available

Activities

Collapse all

Employment (1)

university of Florence: Florence, IT

2014-05-01 to 2016 | post-doc (Department of Experimental and Clinical Biomedical Sciences)
Employment
Source: Self-asserted source
Ignazia Tusa

Education and qualifications (6)

university of Florence: Florence, IT

2014-05-01 to 2016 | Post-doc (Department of Experimental and Clinical Biomedical Sciences)
Education
Source: Self-asserted source
Ignazia Tusa

universirty of Florence: Florence, IT

2014-02-26 | Ph.D. degree (Department of Experimental and Clinical Biomedical Sciences)
Education
Source: Self-asserted source
Ignazia Tusa

university of Florence: Florence, IT

2011-01-01 to 2013-12-31 | Ph.D. programme in Biomedical Sciences (curriculum: Experimental and Clinical Oncology) (Department of Experimental and Clinical Biomedical Sciences)
Education
Source: Self-asserted source
Ignazia Tusa

university of Pisa: Pisa, IT

2009-03-14 to 2010-03-14 | Fellowship (Department of biology)
Education
Source: Self-asserted source
Ignazia Tusa

University of Pisa: Pisa, IT

2006-10-01 to 2008-09-30 | Second-level degree in Biological Sciences (curriculum: Genetics) (Department of biology)
Education
Source: Self-asserted source
Ignazia Tusa

University of Palermo: Palermo, IT

2002-09-01 to 2006-09-06 | First-level degree in Biological Sciences (curriculum: Molecular Biology) (Department of Biological Sciences)
Education
Source: Self-asserted source
Ignazia Tusa

Works (11)

Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress

Cells
2023-04 | Journal article | Author
DOI: 10.3390/cells12081154
Contributors: Ignazia Tusa; Alessio Menconi; Alessandro Tubita; Elisabetta Rovida
Source: check_circle
Multidisciplinary Digital Publishing Institute

Targeting MAPK in Cancer 2.0

International Journal of Molecular Sciences
2022-05 | Journal article | Author
DOI: 10.3390/ijms23105702
Contributors: Elisabetta Rovida; Ignazia Tusa
Source: check_circle
Multidisciplinary Digital Publishing Institute

Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy

International Journal of Molecular Sciences
2020-01 | Journal article | Author
DOI: 10.3390/ijms21030938
Contributors: Alessandro Tubita; Zoe Lombardi; Ignazia Tusa; Persio Dello Sbarba; Elisabetta Rovida
Source: check_circle
Multidisciplinary Digital Publishing Institute

Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells.

2015 | Journal article
DOI: 10.1080/15384101.2015.1078029
PMID: 26291130
Contributors: Del Poggetto E; Tanturli M; Ben-Califa N; Gozzini A; Tusa I; Cheloni G; Marzi I; Cipolleschi MG; Kashman Y; Neumann D et al.
Source: Self-asserted source
Ignazia Tusa via Europe PubMed Central

The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma.

2015-09 | Journal article
DOI: 10.1136/gutjnl-2014-306761
PMID: 25183205
Contributors: Rovida E; Di Maira G; Tusa I; Cannito S; Paternostro C; Navari N; Vivoli E; Deng X; Gray NS; Esparís-Ogando A et al.
Source: Self-asserted source
Ignazia Tusa via Europe PubMed Central

Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.

2015-02 | Journal article
PMID: 25544768
PMC: PMC4385846
Contributors: Cannito S; Turato C; Paternostro C; Biasiolo A; Colombatto S; Cambieri I; Quarta S; Novo E; Morello E; Villano G et al.
Source: Self-asserted source
Ignazia Tusa via Europe PubMed Central

The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.

2014 | Journal article
DOI: 10.4161/15384101.2014.964107
PMID: 25485495
PMC: PMC4612663
Contributors: Rovida E; Peppicelli S; Bono S; Bianchini F; Tusa I; Cheloni G; Marzi I; Cipolleschi MG; Calorini L; Sbarba PD
Source: Self-asserted source
Ignazia Tusa via Europe PubMed Central

Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells.

2014-08 | Journal article
DOI: 10.1038/onc.2013.542
PMID: 24362524
PMC: PMC4141303
Contributors: Barbetti V; Morandi A; Tusa I; Digiacomo G; Riverso M; Marzi I; Cipolleschi MG; Bessi S; Giannini A; Di Leo A et al.
Source: Self-asserted source
Ignazia Tusa via Europe PubMed Central

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia.

2013 | Journal article
DOI: 10.1038/cddis.2013.49
PMID: 23492767
PMC: PMC3613827
Contributors: Barbetti V; Tusa I; Cipolleschi MG; Rovida E; Dello Sbarba P
Source: Self-asserted source
Ignazia Tusa via Europe PubMed Central

Non-thermal effects of 2.45 GHz microwaves on spindle assembly, mitotic cells and viability of Chinese hamster V-79 cells.

2011-11 | Journal article
DOI: 10.1016/j.mrfmmm.2011.07.009
PMID: 21827772
Contributors: Ballardin M; Tusa I; Fontana N; Monorchio A; Pelletti C; Rogovich A; Barale R; Scarpato R
Source: Self-asserted source
Ignazia Tusa via Europe PubMed Central

Spontaneous and bleomycin-induced chromosome damage in non cancer thyroid patients.

2009-12 | Journal article
DOI: 10.1111/j.1365-2362.2009.02214.x
PMID: 19807783
Contributors: Scarpato R; Tusa I; Antonelli A; Fallhai P; Sbrana I
Source: Self-asserted source
Ignazia Tusa via Europe PubMed Central
How many people are using ORCID?